The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis

[EN] Lysophosphatidicacid (LPA )is a phospholipid that i smainly produced by the hydrolysis of lysopho- sphatidylcholine (LPC) by lysophospholipase D, which is also called autotaxin (ATX).LPA interacts with specific G-protein coupled receptors and is involved in the regulation of cellular survival,...

Descripción completa

Detalles Bibliográficos
Autores: Orosa Puente, Beatriz, García Pérez, Samuel, Conde Muro, Carmen
Tipo de recurso: artículo
Fecha de publicación:2015
País:España
Institución:Servizo Galego de Saúde (SERGAS)
Repositorio:RUNA. Repositorio da Consellería de Sanidade e Sergas
OAI Identifier:oai:runa.sergas.gal:20.500.11940/17741
Acceso en línea:https://pubmed.ncbi.nlm.nih.gov/26297977/
http://hdl.handle.net/20.500.11940/17741
Access Level:acceso abierto
Palabra clave:Apoptosis
Synoviocytes
Lysophospholipase
Synovial Fluid
Arthritis, Experimental
Arthritis
Synovial Membrane
Signal Transduction
Phosphoric Diester Hydrolases
Conflict of Interest
Arthritis, Rheumatoid
RNA, Messenger
Lysophospholipids
apoptosis
líquido sinovial
membrana sinovial
diéster fosfórico hidrolasas
lisofosfolipasa
lisofosfolípidos
artritis experimental
transducción de señales
artritis
artritis reumatoide
ARN mensajero
IDIS
CHUS
Descripción
Sumario:[EN] Lysophosphatidicacid (LPA )is a phospholipid that i smainly produced by the hydrolysis of lysopho- sphatidylcholine (LPC) by lysophospholipase D, which is also called autotaxin (ATX).LPA interacts with specific G-protein coupled receptors and is involved in the regulation of cellular survival, proliferation,differentiation and motility . LPA also has roles in several pathological disorders, such as cancer and pulmonary, dermal and renal fibrosis. The involvement of the ATX–LPA pathway has recently been demonstrated in inflammatory responses and apoptosis of fibroblast like synoviocytes (FLS) from patients with rheumatoid arthritis and during the development of experimental arthritis.This review summarises the current literature of the ATX–LPA pathway in rheumatoid arthritis.